Provided by Tiger Fintech (Singapore) Pte. Ltd.

VistaGen Therapeutics

2.32
+0.08003.57%
Volume:47.60K
Turnover:110.53K
Market Cap:66.96M
PE:-1.50
High:2.38
Open:2.30
Low:2.26
Close:2.24
Loading ...
Feb 13, 2020

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Feb 11, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Jan 31, 2020

Major Issues Report

Current report, items 3.01, 8.01, and 9.01
Jan 29, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Jan 27, 2020

Major Issues Report

Current report, items 1.01, 3.02, and 9.01
Dec 27, 2019

Major Issues Report

Current report, items 7.01, 8.01, and 9.01
Dec 12, 2019

Major Issues Report

Current report, items 8.01 and 9.01
Nov 14, 2019

Major Issues Report

Current report, items 7.01 and 9.01
Nov 08, 2019

Major Issues Report

Current report, items 2.02, 3.02, and 9.01
Nov 07, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Oct 30, 2019

Major Issues Report

Current report, items 8.01 and 9.01
Oct 09, 2019

Major Issues Report

Current report, items 7.01, 8.01, and 9.01
Oct 03, 2019

Correspondence

[Cover]Correspondence
Oct 01, 2019

Employee Stock Ownership

Securities to be offered to employees in employee benefit plans, post-effective amendments
Oct 01, 2019

Employee Stock Ownership

Securities to be offered to employees in employee benefit plans
Sep 25, 2019

Major Issues Report

Current report, item 8.01
Sep 06, 2019

Major Issues Report

Current report, items 5.03, 5.07, and 9.01
Aug 23, 2019

Major Issues Report

Current report, item 3.01
Aug 16, 2019

Major Issues Report

Current report, items 2.02, 7.01, 8.01, and 9.01
Aug 13, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]